Monitoring pregnant women's illicit opiate and cocaine use with sweat testing

Therapeutic Drug Monitoring

Volumn 32, Issue 1, 2010, Pages 40-49

  Brunet, Bertrand R ^a   Barnes, Allan J ^b   Choo, Robin E ^c   Mura, Patrick ^d   Jones, Hendrée E ^e   Huestis, Marilyn A ^b  

^a UNIVERSITÉ DE POITIERS   (France)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Cocaine; Heroin; Opiates; Sweat; Sweat patch

Indexed keywords

ACETYLCODEINE; BENZOYLECGONINE; COCAINE; CODEINE; DIAMORPHINE; ECGONINE METHYL ESTER; MORPHINE; MORPHINE 6 ACETATE; OPIATE;

ADULT; ARTICLE; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG MONITORING; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; SUBSTANCE ABUSE; SWEAT TEST;

ADULT; COCAINE-RELATED DISORDERS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEROIN DEPENDENCE; HUMANS; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; SOLID PHASE EXTRACTION; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SWEAT; YOUNG ADULT;

EID: 75649129682     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181c13aaf     Document Type: Article

References (35)

1. Freier MC, Griffith DR, Chasnoff IJ. In utero drug exposure: developmental follow-up and maternal-infant interaction. Semin Peri-natol. 1991;15:310-316.
2. Wheeler SF. Substance abuse during pregnancy. Primary Care. 1993;20: 191207.
3. Havens JR, Simmons LA, Shannon LM, et al. Factors associated with substance use during pregnancy: results from a national sample. Drug Alcohol Depend. 2009;99:89-95.
4. Jansson LM, Svikis D, Lee J, et al. Pregnancy and addiction. A comprehensive care model. J Subst Abuse Treatm. 1996;13:321-329.
5. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend. 2008;96:69-78.
6. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci. 2007;1098:51-103.
7. Cone EJ, Sampson-Cone A, Huestis MA. Interpreting alternative matrix test results. In: Karch SB, ed. Drug Abuse Handbook. Boca Raton: CRC Press; 2006:814-828.
8. Dams R, Choo RE, Lambert WE, et al. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend. 2007;87:258-267.
9. Kintz P, Bernhard W, Villain M, et al. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after intercept device collection. J Anal Toxicol. 2005;29:724-727.
10. SAMHSA Administration. Available at: http://workplace.samhsa.gov/. 2004:1.
11. Taylor JR, Watson ID, Tames FJ, et al. Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing. Addiction. 1998;93:847-853.
12. Barnes AJ, Smith ML, Kacinko SL, et al. Excretion of methamphetamine and amphetamine in human sweat following controlled oral metham-phetamine administration. Clin Chem. 2008;54:172-180.
13. Schwilke EW, Barnes AJ, Kacinko SL, et al. Opioid disposition in human sweat after controlled oral codeine administration. Clin Chem. 2006;52: 1539-1545.
14. Kacinko SL, Barnes AJ, Schwilke EW, et al. Disposition of Cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem. 2005;51:2085-2094.
15. Preston KL, Huestis MA, Wong CJ, et al. Monitoring cocaine use in substance abuse treatment patients by sweat and urine testing. J Anal Toxicol. 1999;23:313-322.
16. Huestis MA, Cone EJ, Wong CJ, et al. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol. 2000;24:509-521.
17. Bush DM. The US Mandatory Guidelines for Federal Workplace Drug Testing Programs: Current status and future considerations. Forensic Sci Int. 2008;174:111-119.
18. Skopp G, Pötsch L. Perspiration versus saliva-basic aspects concerning their use in roadside drug testing. Int J Legal Med. 1999;112:213-221.
19. Huestis MA, Oyler JM, Cone EJ, et al. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr. 1999;733:247-264.
20. Cone EJ, Hillsgrove MJ, Jenkins AJ, et al. Sweat testing for heroin, cocaine, and metabolites. J Anal Toxicol. 1994;18:298-305.
21. Kintz P, Brenniesen R, Bundeli P, et al. Sweat testing for heroin and metabolites in a heroin maintenance program. Clin Chem. 1997;43: 736-739.
22. Pichini S, Navarro M, Pacifici R, et al. Usefulness of sweat testing for the detection of MDMA after a single-dose administration. J Anal Toxicol. 2003;27:294-303.
23. Huestis MA, Scheidweiler KB, Saito T, et al. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Sci Int. 2008;174:173-177.
24. Brunet BR, Barnes AJ, Scheidweiler KB, et al. Development and validation of a solid-phase extraction gas chromatography-mass spec-trometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem. 2008;392: 115-127.
25. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem. 1984;30:290-292.
26. Barnes AJ, De Martinis BS, Gorelick DA, et al. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clin Chem. 2009;55:454-462.
27. Liberty HJ, Johnson BD, Fortner N, et al. Detecting crack and other cocaine use with fastpatches. Addict Biol. 2003;8:191200.
28. Fucci N, De Giovanni N. Methadone in hair and sweat from patients in long-term maintenance therapy. Ther Drug Monit. 2007;29: 452-454.
29. Kintz P, Tracqui A, Mangin P, et al. Sweat testing in opioid users with a sweat patch. J Anal Toxicol. 1996;20:393-397.
30. Sunshine I, Sutliff JP. Sweat it out. In: Wong SHY, Sunshine I, eds. Handbook of Analytical Therapeutic Drug Monitoring and Toxicology. New York: CRC Press; 1997:253-264.
31. Chawarski MC, Fiellin DA, O'Connor PG, et al. Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. J Subst Abuse Treatm. 2007;33:411-415.
32. Spiehler V, Fay J, Fogerson R, et al. Enzyme immunoassay validation for qualitative detection of cocaine in sweat. Clin Chem. 1996;42:34-38.
33. Levisky JA, Bowerman DL, Jenkins WW, et al. Drug deposition in adipose tissue and skin: evidence for an alternative source of positive sweat patch tests. Forensic Sci Int. 2000;110:35-46.
34. Kintz P. Drug testing in addicts: a comparison between urine, sweat, and hair. Ther Drug Monit. 1996;18:450-455.
35. Kintz P, Bundeli P, Brenneisen R, et al. Dose-concentration relationships in hair from subjects in a controlled heroin-maintenance program. J Anal Toxicol. 1998;22:231-236.